REG-GSK Plc: Director/PDMR Shareholding

GSKAnnouncement

25/05/2022 15:45

GSK plc (the ‘Company’)

Transaction notification

 1.  Details of PDMR/person closely associated with them (‘PCA’)                                                                                                                                                  
 a)  Name                                     Dr H Barron                                                                                                                                                         
 b)  Position/status                          Chief Scientific Officer and President, R&D                                                                                                                         
 c)  Initial notification/ amendment          Initial notification                                                                                                                                                
 2.  Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor                                                                                                
 a)  Name                                     GSK plc                                                                                                                                                             
 b)  LEI                                      5493000HZTVUYLO1D793                                                                                                                                                
 3.  Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted           
 a)  Description of the financial instrument  American Depositary Shares (‘ADSs’)  ISIN: US37733W1053                                                                                                             
 b)  Nature of the transaction                Acquisition of notional ADSs within Dr Barron’s GSK Executive Supplemental Savings Plan account.                                                                    
 c)  Price(s) and volume(s)                                                            Price(s)                                 Volume(s)                                                                         
                                                                                       $44.7500                                 1,151.020                                                                         
                                                                                                                                                                                                                  
 d)  Aggregated information                   N/A (single transaction)                                                                                                                                            
     Aggregated volume Price                                                                                                                                                                                      
 e)  Date of the transaction                  2022-05-23                                                                                                                                                          
 f)  Place of the transaction                 New York Stock Exchange (XNYS)                                                                                                                                      



Copyright (c) 2022 PR Newswire Association,LLC. All Rights Reserved